No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
NRXPW NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM)
- 0.1500
- +0.0036+2.46%
Trading Apr 26 09:53 ET
0Market Cap0.00P/E (TTM)
0.1500High0.1471Low28.71KVolume0.1471Open0.1464Pre Close4.28KTurnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.390052wk High0.00P/B0Float Cap0.050052wk Low--Dividend TTM0Shs Float16.1000Historical High--Div YieldTTM1.98%Amplitude0.0500Historical Low0.1490Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice From Nasdaq That the Company Has Demonstrated Compliance With the Bid Price Requirement
NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights
UPDATE: NRx Pharmaceuticals (NASDAQ: NRXP) to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Plan to Distribute Shares of HOPE Therapeutics and Royalty Rights on Ketamine Sales to Existing NRx Shareholders
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg